lungcancer,nsclc,oncology

Mashup Score: 3

Findings for Zidesamtinib in Advanced ROS1+ NSCLC and Other Solid Tumors - 14 day(s) ago

Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss data for zidesamtinib in ROS1-positive non–small cell lung cancer.

Source: www.onclive.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- OncLive
  
  Gregory J. Riely, MD, PhD, of @MSKCancerCenter and @BenjaminBesseMD, of @GustaveRoussy discuss data for zidesamtinib in ROS1-positive non–small cell #lungcancer. #nsclc #oncology Watch more here: https://t.co/3LUasDEfTt https://t.co/RCjeUSkSuF